Navigation Links
Plant stem cells could be fruitful source of low-cost cancer drug
Date:10/25/2010

A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.

Researchers have isolated and grown stem cells from a yew tree whose bark is a natural source of the anticancer compound paclitaxel. The development could enable the compound to be produced on a commercial scale at low cost, with no harmful by-products.

Scientists and engineers behind the development say the drug treatment currently used on lung, ovarian, breast, head and neck cancer could become cheaper and more widely available. The study was carried out by the University of Edinburgh and the Unhwa Biotech company in Korea.

Currently, an extract from yew tree bark is used to industrially manufacture the compound paclitaxel. However, this process is expensive, requires supplies of mature trees, and creates environmentally damaging by-products.

Researchers claim that using stem cells self-renewing tree cells which can be manipulated to produce large amounts of the active compound would effectively create an abundant supply of the drug. The process would cost far less than conventional methods.

Scientists behind the project have also cultured stem cells from other plants with medical applications, indicating that the technique could be used to manufacture other important pharmaceuticals besides paclitaxel.

The study was published in Nature Biotechnology and supported by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.

Professor Gary Loake, of the University of Edinburgh's School of Biological Sciences, who led/took part in the study, said: "Plants are a rich source of medicine around one in four drugs in use today is derived from plants. Our findings could deliver a low-cost, clean and safe way to harness the healing power of plants, potentially helping to treat cancer, and other conditions."


'/>"/>

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion
2. Vitamin D deficiency linked to lung transplant rejection
3. OHSU research suggests compound administered during some bone marrow transplants elevates risks
4. Kings College London reveals promising techniques for extending the life of an organ transplant
5. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
6. Biosynthetic Corneas Show Promise in Transplants
7. Decade-long trial confirms benefts of steroid withdrawal for transplant patients
8. Hispanics and Asians less likely to receive liver transplants
9. Study identifies factors which predict alcohol use after liver transplantation
10. Chronic health conditions common for stem cell transplant survivors
11. Plant compound resveratrol shown to suppresses inflammation, free radicals in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... ... “Mysteries Revealed On Speaking In Tongues”: an engaging and dynamic study on ... Revealed On Speaking In Tongues” is the creation of published author, Tina Jackson, the ... Michigan. , “We need to partner with Jesus and be the voice piece ...
(Date:1/24/2017)... TEXAS (PRWEB) , ... January ... ... Texas-based healthcare and clinical research networking-technology company founded by patient survivors, today ... innovative BlueCloud® business model, networking technologies and patient-inspired initiatives. , Like ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... protein and espresso drink, announced its CLICK® Coffee Protein Drink is now available ... Protein Drink Mix has become popular among health-conscious consumers who love coffee but ...
(Date:1/24/2017)... , ... January 23, 2017 , ... ... with Plug and Play, the world’s largest start-up platform headquartered in Silicon Valley ... year. , OSF Ventures recently signed a three-year agreement to be a ...
(Date:1/24/2017)... ... January 23, 2017 , ... The January 2017 issue of the ... study on how outdoor behavioral healthcare (OBH) – also known as wilderness therapy – ... while experiencing an increased sense of purpose both during and after treatment. , ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... For today, Stock-Callers.com scans the following Biotechnology companies: ... Inc. (NASDAQ: ALDR ), BioDelivery Sciences International Inc. ... EGLT ). These equities are part of the Healthcare ... , 2017, with the NYSE Health Care Index dropping about ... 500 also were down 0.3% as a group. These stocks ...
(Date:1/24/2017)... -- Laboratory Markets Limited has completed a comprehensive market ... both clinical and research laboratory settings. This study, which ... $6.8 billion and growing to $9.2 billion (CAGR of ... of mass spectrometry across more than 5,200 clinical and ... in the use of mass spectrometry in terms of ...
(Date:1/24/2017)... ArisGlobal, a leading provider of integrated, cloud-based ... latest version of its comprehensive clinical trial management software. ... and efficiently meet new compliance and submission requirements, improve ... file so that compliance is assured and transparency is ... ...
Breaking Medicine Technology: